Patients and Visitors

In this Section
For information or to register for screening in a selected trial, call HealthMatch (216) 844-5000
How to enroll
Search the listing of clinical trials below. When you find one which is appropriate for you click more information and you can apply by contacting us directly by phone or by online application form.
Clinical Trials

A Clinical Trial is a research study to answer specific questions about new therapies or new ways of using established treatments. Clinical Trials are used to determine whether new drugs or treatments are both safe and effective. Most current drug therapies were initially developed in past Clinical Trials.

Participants include men, women and children of all ages, races, religions and ethnic backgrounds, depending on the study guidelines. Protection of the rights, safety and welfare of our research participants is always our primary concern. Clinical Trial participants are seen regularly by the research staff to monitor their health and to determine the safety and effectiveness of their treatment. Each Clinical Trial is approved by the Institutional Review Board consisting of healthcare professionals as well as lay people from the community to ensure that risks are monitored and federal regulations are followed.

What follows is a brochure of some of the hundreds of Clinical Trials at University Hospitals of Cleveland that are actively recruiting participants. If you would like to participate, please note that each trial is listed with study-specific contact information. You may also enroll online by selecting the "Enroll in Clinical Trials" link at the left of this screen.

We hope you find this brochure useful, and that you will share it with friends and family who may benefit from one of the studies.

Nathan Levitan, MD
Chief Medical Officer
University Hospitals of Cleveland


Find a Clinical Trial
Trial Name:

ACCL 0331 (Stratum UCN suspended)

Intro: A Randomized Double Blind Placebo Controlled Trial to Assess the Efficacy of Traumeel S for the Prevention and Treatment of Mucositis in Children Undergoing Hematopoietic Stem Cell Transplantation
Condition:
Description: This study will determine if Traumeel® S can prevent and treat mouth sores (mucositis) and/or lessen the pain and discomfort of existing mouth sores in patients having stem cell transplantation. Traumeel® S is a natural medicine made from several plants and minerals. Patients will be randomly chosen to be given either a mouth rinse with the Traumeel® S treatment or a placebo mouth rinse. Patients will be asked to rinse their mouths or hold the solution in their mouths for thirty seconds and then swallow it. Treatment will start the day before the transplant and stop on Day #20 (this would be equal to of 22 days of treatment with Traumeel® S ), or when the mouth sores are gone, but no earlier than Day #12 (this would be equal to 14 days of Traumeel® S treatment).
Criteria: 1. Can be undergoing allogenic, or autologous hematopoietic stem cell transplant with source of stem cells being bone marrow, placenta blood or cytokine mobilized peripheral blood; receiving any type of GVHD prophylaxis; patients receiving any type of myeloablative stem cell transplant conditioning regimen (patients receiving non-myeloablative chemotherapy are excluded) 2. Must be between 3 and 25 years old 3. Cannot be receiving oral vancomycin paste or glutamine as an oral supplement 4. Cannot have a known allergy to Echinacea
Contact: For Cancer Information, Current Clinical Trials, and Referral to a Physician please call (216) 844-5432 or (800) 641-2422

Participant Confidentiality:

All information regarding participation in Clinical Trials is treated with the utmost confidentiality. University Hospitals Case Medical Center and the Division of Clinical Research recognize and respect the confidentiality of this information. Access to information related to clinical trials and their participants is restricted to authorized clinical trials personnel only.

Back